COMMUNIQUÉS West-GlobeNewswire

Terveystalo's occupational health services to expand: Terveystalo acquires the occupational health operations from Welfare District of Forssa
17/06/2019
Press Release 17 June 2019 Terveystalo will buy the occupational health operations of Welfare District of Forssa by an agreement signed on 17 June 2019. Terveystalo will also become the occupational health care provider [...]
NeuroSearch announces a change to its financial outlook for 2019
17/06/2019
Company announcement 17 June 2019 In its Annual Report 2018, NeuroSearch announced an expected operating loss (on a going-concern assumption) of approximately DKK 4-6 million. The expectations did not include expenses [...]
VBI Vaccines to Host Conference Call Tomorrow to Review PROTECT Phase 3 Clinical Data for Sci-B-Vac®
16/06/2019
CAMBRIDGE, Mass., June 16, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, will [...]
Strategy update for the three-year period 2020-2022
16/06/2019
Read the full announcement in PDF Attachment 2019_18_Strategy 2020-2022_20190616 EN
Apellis Pharmaceuticals
16/06/2019
CRESTWOOD, Ky. and WALTHAM Mass., 16 juin 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), une société biopharmaceutique de stade clinique axée sur le développement de nouveaux composés [...]
ROADSTER-2 Demonstrates Compelling Patient Outcomes with Strong Safety Profile
15/06/2019
Final Results Presented in Late-Breaking Session at Society for Vascular Surgery 2019 Vascular Annual Meeting NATIONAL HARBOR, Md., June 15, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company [...]
Sunesis Pharmaceuticals Announces Presentation of Preliminary Data from Phase 1b/2 Trial of Vecabrutinib in Patients with CLL and Other B-Cell Malignancies at EHA Annual Meeting
15/06/2019
SOUTH SAN FRANCISCO, Calif., June 15, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced the presentation of results from the Company’s Phase 1b/2 clinical trial of its non-covalent [...]
Editas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell Disease and Beta-Thalassemia at the 24th Congress of the European Hematology Association
15/06/2019
IND-enabling activities initiated for EDIT-301, a potentially best-in-class experimental medicine for the treatment of sickle cell disease and beta-thalassemia CAMBRIDGE, Mass., June 15, 2019 (GLOBE NEWSWIRE) -- Editas [...]
Apellis Pharmaceuticals Presents Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at 24th European Hematology Association (EHA) Congress
15/06/2019
CRESTWOOD, Ky. and WALTHAM Mass., June 15, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Forty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma
15/06/2019
-- 5F9 Well-Tolerated in Combination with Rituximab -- -- Durable Responses Observed in DLBCL and Indolent Lymphoma; Median Duration of Response Not Yet Reached -- -- Overall Response Rate (ORR) of 36% Observed in DLBCL [...]
Emerald Health Therapeutics applaudit le gouvernement du Canada pour la publication de la version définitive des réglementations encadrant les produits ingérables
15/06/2019
Le cadre de réglementation finale permet à Emerald de poursuivre sa croissance VANCOUVER, 15 juin 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV: EMH; OTCQX: EMHTF) est ravie que le [...]
Aclaris Therapeutics to Present at the 2019 JMP Securities Life Sciences Conference
14/06/2019
WAYNE, Pa., June 14, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory and dermatological diseases, today announced that [...]
UPDATE - OraSure Technologies to Present at Raymond James 2019 Life Sciences and MedTech Conference
14/06/2019
[Updated Release to Correct Date of Presentation] BETHLEHEM, Pa., June 14, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, [...]
Emerald Health Therapeutics Applauds the Government of Canada for the Release of Final Ingestible Regulations
14/06/2019
Final regulatory framework positions Emerald for further growth VANCOUVER, British Columbia, June 14, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) is pleased that [...]
UPDATE - Mesoblast to Host Virtual Symposium With Key Opinion Leader Highlighting Acute Graft Versus Host Disease
14/06/2019
NEW YORK and MELBOURNE, Australia, June 14, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ: MESO; ASX: MSB), global leader in cellular medicines for inflammatory diseases, today announced that it will host a virtual [...]
Canada House Wellness Group Inc. Update on Canada House Clinic Expansion
14/06/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 14, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”), a fully [...]
Cytovance® Biologics Inc., Completes Its Second FDA Pre-Approval Inspection (PAI) of Oklahoma City, OK Facilities
14/06/2019
OKLAHOMA CITY, June 14, 2019 (GLOBE NEWSWIRE) -- Cytovance® Biologics announced that it has received a notification letter and an Establishment Inspection Reports (EIRs) from the U.S. Food and Drug Administration (FDA) [...]
LifePod and iHome Announce Strategic Collaboration to Launch Groundbreaking Proactive-Voice Virtual Caregiver Service
14/06/2019
BOSTON, June 14, 2019 (GLOBE NEWSWIRE) -- During CE Week in New York, LifePod Solutions Inc. announced a strategic collaboration with SDI Technologies Inc., and their iHome division, to bring to market a first-of-its- [...]
Mesoblast to Host Virtual Symposium With Key Opinion Leader Highlighting Acute Graft Versus Host Disease
14/06/2019
NEW YORK and MELBOURNE, Australia, June 14, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ: MESO; ASX: MSB), global leader in cellular medicines for inflammatory diseases, today announced that it will host a virtual [...]

Pages